Skip to main content
. 2023 Aug 14;15(8):4367–4378. doi: 10.21037/jtd-22-697

Figure 1.

Figure 1

Clinical scenarios with all lesions measured at <2 cm—comparison among the four cohorts. Both EGFRm (A-C) and ALK+ (D-F) specific scenarios are represented. EGFR, epidermal growth factor receptor; ALK, anaplastic lymphoma kinase; MO, medical oncologist; CO, clinical oncologist; RO, radiation oncologist; NS, neurosurgery.